Yes, it works for Chinese domestic manufacturer. According to the explanation from China NMPA (previous CFDA) in 2018/07, the guidance also applies to Chinese domestic manufacturer who uses overseas clinical data for product registration in China. By the way, there is no mention about where the manufacturer is. It only talks about oversea clinical data. Hope this can help.
------------------------------
Colin Lai
Watkinsville GA
United States
------------------------------
Original Message:
Sent: 23-Jan-2019 13:58
From: Anonymous Member
Subject: China - Use of Overseas Clinical Trial Data for medical devices
This message was posted by a user wishing to remain anonymous
Hello,
I know CFDA has allowed the use of overseas medical device trial data for manufacturers registering in China. However, my understanding is that this option is available to foreign device manufacturers located outside of China. What if you are a domestic Chinese manufacturer registering a product in China. What if this Chinese company has a foreign partner with the same device outside of China? Can the Chinese manufacturer leverage clinical trial data from abroad. Let me rephrase: is the option to use foreign device clinical trial data also available to domestic Chinese manufacturers who wish to leverage data from abroad? Thanks!